COMPANY PROFILE / #1324
Elion Therapeutics
Boston, MAVenture Capital-Backed
OVERVIEW
Provider of clinical research and development services intended to treat systemic and life-threatening fungal infections. The company's services focus on the improvement of the Amphotericin B drug, enabling patients to receive a broad spectrum of antifungal drugs that are completely non-toxic in mammalian cells.
已融资111.00
最新估值163.00
员工数18
成立年份2018
公司概况
- Companies
- Elion Therapeutics
- Description
- Provider of clinical research and development services intended to treat systemic and life-threatening fungal infections. The company's services focus on the improvement of the Amphotericin B drug, enabling patients to receive a broad spectrum of antifungal drugs that are completely non-toxic in mammalian cells.
- Website
- www.eliontx.com
- HQ Location
- Boston, MA
- Year Founded
- 2018
- Keywords
- antifungal drug, antifungal medicine, biotechnology data, fungal infection treatment, mammalian cell, pharmaceuticals firm
- Competitors
- Cidara Therapeutics, Scynexis, Innoviva Specialty Therapeutics
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 111.00
- First Financing Date
- —
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 19-Aug-2025
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 81.00
- Last Financing Valuation
- 163.00
- Last Financing Status
- Completed
- Last Known Valuation
- 163.00
- Last Known Valuation Date
- 19-Aug-2025
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 272.68
- Valuation Estimate Growth Rate
- 67.29%
- Active Investors
- AMR Action Fund, Deerfield Management, Illinois Ventures
- # Active Investors
- 3
- Acquirers
- —
团队与联系人
- Employees
- 18
- Employee Growth %
- 38.46%
- Employee History
- 2026: 18, 2025: 13
- Primary Contact
- Martin Burke
- Primary Contact Title
- Co-Founder
- Primary Contact Email
- —
- Primary Contact Phone
- +1 (781) 562-1840
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.37%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 93
- Size Multiple
- 1.70x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 67
- Majestic Referring Domains
- 30
- SimilarWeb Unique Visitors
- 270
- SimilarWeb Unique Visitors Change
- 13
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 17%
- Success Probability Over Time – 3 Year
- 46%
- Success Probability Over Time – 5 Year
- 56%
记录来源：public.companies · 原始序号 #1324 · 所有字段均按数据库原值展示。